• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Teen drivers ignore cell phone ban

Article

Survey results show that a North Carolina cell phone ban for young drivers did not lower their cell phone use, according to the Insurance Institute for Highway Safety.

Survey results show that a North Carolina cell phone ban for young drivers did not lower their cell phone use, according to the Insurance Institute for Highway Safety.

Between one and two months before the ban took effect in December 2006, cell phone use among teen drivers was at 11%. About five months after the ban took effect, nearly 12% of teen drivers were using their phones, most of which where hand-helds.

Fewer than 1% of teens were observed using hands-free devices, while about 2% were observed dialing or texting while driving.

At the 22nd Annual Meeting of the Associated Professional Sleep Societies, a separate study found that participants ages 14 to 20 who made or received more than 15 calls or text messages a day increased their risk for disturbed sleep compared to those who used their cell phones fewer than five times a day.

The heavy cell phone users in the pilot study also had more difficulty waking up and felt more tired during the day than light cell phone users, the investigators reported.

Related Videos
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Scott Ceresnak, MD
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
© 2024 MJH Life Sciences

All rights reserved.